Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland
Abstract
Rehm, J., Rehm, M. X., Alho, H., Allamani, A., Aubin, H., Bühringerm G,m Daeppen, J., Frick, U., Gual, A., & Heather, N. (2013). Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland. International Journal of Alcohol and Drug Research, 2(2), 53-67. doi: 10.7895/ijadr.v2i2.89 (http://dx.doi.org/10.7895/ijadr.v2i2.89)
Aim: To describe guidelines and common practices for alcohol dependence treatment in Europe.
Design: Systematic and qualitative review; for each country, guidelines were identified via systematic literature research, followed by interviews with treatment experts.
Setting: European Union (EU) countries plus Iceland, Norway, and Switzerland.
Participants: Experts in alcohol dependence treatments and treatment systems.
Measure: Semi-structured questionnaire for interviews.
Findings: While fewer than half of EU countries have formal national guidelines for alcohol dependence treatment, a majority of these countries have guidelines by professional organizations such as psychiatric or neuropsychopharmacologic societies, and several are currently developing such guidelines. Abstinence is the usual treatment goal, but the majority of countries accept reduction of drinking as an intermediate or secondary goal, in practice even more than in the guidelines. Psychotherapy, mainly cognitive-behavioral approaches, motivational interviewing, and family therapy, is the most common treatment for relapse prevention, in part accompanied by pharmacotherapy (disulfiram, acamprosate and naltrexone being used most often).
Conclusions: There are differences in treatment for alcohol dependence in Europe. The introduction of reduction of drinking as one treatment goal may attract more patients.
In consideration of publishing this article the authors transfer, assign, or otherwise convey all copyright ownership to the International Journal of Alcohol and Drug Research. By this transfer, the article becomes the property of the International Journal of Alcohol and Drug Research and may not be published elsewhere without written permission from the journal.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. The author(s) will receive no royalty or other monetary compensation for transferring the copyright of the article to the International Journal of Alcohol and Drug Research. IJADR, in turn, grants each author the right to republish the article, without paying royalties to IJADR, in any book of which he or she is the author or editor, subject to the express conditions that (a) the author notify the International Journal of Alcohol and Drug Research in writing of this republication and (b) a credit line attributes the original publication to the International Journal Of Alcohol and Drug Research.
Licence:
Articles are licenced with a Creative Commons License Deed -- you are free to share articles but must give appropriate attribution, may not use for commercial purposes or distribute modified works. See CC/BY-NC/ND/4.0/.
Author Agreement:
As the submitting author, and on behalf of all of the manuscript authors I agree with the terms above relating to the copyright transfer of the manuscript to the International Journal of Alcohol and Drug Research.
